The Comparative Effect of Combination of Metformin and Megestrol Acetate With Megestrol Acetate Alone on Endometrial Growth Disorders

The Comparative Effect of Combination of Metformin and Megestrol Acetate With Megestrol Acetate Alone on Endometrial Growth Disorders


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: پروین مصطفی قره باغی , الهه اولاد صاحب مدارک , مهری جعفری شبیری , وحیده رحمانی , منیژه سیاح ملی

کلمات کلیدی: Endometrial hyperplasia, Endometrial proliferative disorders, Metformin, Megestrol acetate

نشریه: 0 , 2 , 6 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله منیژه سیاح ملی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه سلامت باروری زنان
کد مقاله 62623
عنوان فارسی مقاله The Comparative Effect of Combination of Metformin and Megestrol Acetate With Megestrol Acetate Alone on Endometrial Growth Disorders
عنوان لاتین مقاله The Comparative Effect of Combination of Metformin and Megestrol Acetate With Megestrol Acetate Alone on Endometrial Growth Disorders
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) International Journal of Women’s Health and Reproduction Sciences
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Objectives: Endometrial hyperplasia has an affinity for progression toward endometrial carcinoma. This study was conducted to compare the effect of metformin plus megestrol acetate with megestrol acetate alone on endometrial histology in the patients with endometrial proliferative and hyperplastic disorders. Materials and Methods: In a single-blind clinical trial, 96 patients with abnormal uterine bleeding and endometrium with irregular or hyperplastic glands with or without atypical foundations were divided randomly into 2 equal groups. Group1 received metformin 500 mg twice a day plus megestrol acetate 40 mg daily for 3 months and group 2 received megestrol acetate 40 mg/d for 3 months. The treatment response was evaluated using pathologic samples of endometrial biopsies 2 weeks after completing the treatment. Results: In both groups, endometrial hyperplasia was resolved in most cases. Significant decrease was observed within groups in the endometrial thickness before and after the intervention. Comparison of thickness between 2 groups showed that in the megestrol acetate group, after intervention, significant decrease in the endometrial thickness was revealed (12.73 ± 6.04 mm [group 1], versus 8.55 ± 3.43 mm [group 2], P < 0.001). Lack of response to treatment was seen in 7% of group 1 and 4.9% of group 2 (P=0.68). None of the groups showed any complications and there was no hysterectomy. Conclusions: Both treatment modalities were effective in treating proliferative and hyperplastic disorders. However, the response to treatment in the megestrol group was greater than that in the megestrol plus metformin group.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
پروین مصطفی قره باغیسوم
الهه اولاد صاحب مدارکچهارم
مهری جعفری شبیریپنجم
وحیده رحمانیششم
منیژه سیاح ملیاول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
a97-2-dr sayyah-pourazad.pdf1397/01/18632799دانلود